Effective Microorganisms (EM) Improve Internal Organ Morphology, Intestinal Morphometry and Serum Biochemical Activity in Japanese Quails under Clostridium perfringens Challenge

Molecules. 2021 May 8;26(9):2786. doi: 10.3390/molecules26092786.

Abstract

The effect of effective microorganisms (EM) on internal organ morphology, intestinal morphometry, and serum biochemical activity in Japanese quails under Clostridium perfringens challenge was determined. After 30 days of EM addition, one group of quails was orally inoculated with Clostridium perfringens. The second group did not receive EM and was inoculated with C. perfringens. In the gut, EM supplementation reduced the number of lesions, enhanced gut health, and protected the mucosa from pathogenic bacteria. EM showed an anti-inflammatory effect and fewer necrotic lesions in villi. In the internal organs, EM showed a protective effect against a typical lesion of C. perfringens infection. Necrosis and degeneration of the hepatocytes, necrosis of bile ducts, and bile duct proliferation were more severe in the infected group without EM. Morphometric evaluation showed significantly higher villi in the jejunum after EM addition. A greater crypt depth was observed in the C. perfringens group. Biochemical analysis of the blood indicated lower cholesterol on the 12th day of the experiment and between-group differences in total protein, lactate dehydrogenase (LDH), and albumin levels in the EM group. Further studies are needed to improve EM activity against pathologic bacteria as a potential alternative to antibiotics and to develop future natural production systems.

Keywords: Japanese quail; effective microorganisms; histopathology; internal organs; morphometry.

MeSH terms

  • Animal Feed / microbiology
  • Animals
  • Anti-Inflammatory Agents / therapeutic use*
  • Bile Ducts / pathology
  • Bird Diseases / blood*
  • Bird Diseases / diet therapy*
  • Bird Diseases / microbiology
  • Cholesterol / blood
  • Clostridium Infections / blood*
  • Clostridium Infections / diet therapy*
  • Clostridium Infections / microbiology
  • Clostridium perfringens*
  • Enteritis / blood*
  • Enteritis / diet therapy*
  • Enteritis / microbiology
  • Female
  • Hepatocytes / pathology
  • Intestinal Mucosa / microbiology*
  • Intestinal Mucosa / pathology
  • Jejunum / microbiology
  • Jejunum / pathology
  • L-Lactate Dehydrogenase / blood
  • Necrosis
  • Probiotics / therapeutic use*
  • Protective Agents / therapeutic use*
  • Quail / blood*
  • Quail / microbiology*
  • Serum Albumin / analysis
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Protective Agents
  • Serum Albumin
  • Cholesterol
  • L-Lactate Dehydrogenase